Roche Holding Ltd
Total Valuation
CHFAs of June 30, 2026, Roche Holding Ltd carries a market capitalization of 229.94B, placing it among publicly traded companies globally. Its enterprise value stands at 256.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 229.94B |
| Enterprise Value | 256.04B |
Share Statistics
As of June 30, 2026, Roche Holding Ltd has 690.07M shares outstanding.
| Shares Outstanding | 690.07M |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 7.03 |
| P/TBV Ratio | 41.03 |
Financial Position
As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.34 |
| Debt / Equity | 86.62 |
Stock Price Statistics
CHFAs of the close on October 22, 2026, Roche Holding Ltd's stock has declined approximately 14.01% over the past 52 weeks.
| 52-Week Price Change | -14.01% |
| 50-Day Moving Average | 360.92 |
Balance Sheet
CHFAs of June 30, 2026, Roche Holding Ltd holds 9.73B in cash and equivalents against 31.81B in total debt, resulting in a net debt position of 26.36B. Total book value stands at 32.69B, with working capital of 6.59B providing operational flexibility.
| Cash & Cash Equivalents | 9.73B |
| Total Debt | 31.81B |
| Net Debt | 26.36B |
| Equity (Book Value) | 32.69B |
| Book Value Per Share | 47.38 |
| Working Capital | 6.59B |
Stock Splits
Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.
| Last Split Date | 5/4/2001 |
| Split Ratio | 1:100 |